Druggio Logo

Druggio

Soft tissue sarcomas

Soft-tissue sarcomas (STS) are a rare and heterogeneous group of tumors with mesenchymal origin, including muscle, endothelium, cartilage. Several common STSs have recognized translocations, which represent clinical targets. In addition to translocations, other genomic changes and epigenetic mechanisms have been shown to be involved in the histogenesis of STS as well as other cancers.

Drugs that treat Soft tissue sarcomas

Yondelis

Approval date

2015/9/28

Votrient

Approval date

2012/9/28

Halaven

Made by

Eisai

Approval date

2011/4/22